← Evidence map

ArticleRadiation research2026

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.

Caroline P Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs. | OpenQuestion